Cholesterol Drug Halves Heart Attack and Stroke in Early Test

The results, though not conclusive, provide the first evidence that targeting a protein known as PCSK9 could reduce cardiovascular risks for millions of patients.

















from NYT > Business Day http://ift.tt/1uhMoxy